The Latest Apheresis Industry Statistics Explained
The global apheresis market size was valued at USD 1.7 billion in 2019.
The statistic indicates that the global apheresis market had a total value of USD 1.7 billion in the year 2019. Apheresis is a medical procedure that involves separating blood components outside the body and then returning the remaining components to the patient. The market size suggests the monetary value of products, services, and equipment related to apheresis technology and procedures being sold and utilized globally during that time period. This figure serves as a key indicator of the scale and economic significance of the apheresis market, reflecting the demand for apheresis products and services in various healthcare settings worldwide.
The industry is projected to grow at a 7.5% compound annual growth rate (CAGR) between 2020 and2030.
This statistic indicates that the industry is expected to experience consistent growth over the 10-year period from 2020 to 2030, at an average rate of 7.5% per year. The compound annual growth rate (CAGR) takes into account the compounding effect of growth over multiple years, reflecting a steady increase in the industry’s size and value. This projection suggests that the industry is likely to expand significantly and steadily over the next decade, providing opportunities for businesses, investors, and stakeholders involved in the sector. It serves as a valuable metric for forecasting future trends and making informed decisions based on the expected growth trajectory of the industry.
North America had the largest share in the global apheresis market in 2019, estimated at over 45%.
The statistic ‘North America had the largest share in the global apheresis market in 2019, estimated at over 45%’ indicates that North America accounted for a significant portion of the global apheresis market activities during that year. Apheresis is a medical procedure involving the removal of specific components from a patient’s blood, such as plasma or platelets, for therapeutic purposes. The fact that North America held over 45% of the market share suggests that the region was a key player in the apheresis industry, likely due to factors such as technological advancements, high healthcare spending, and a robust healthcare infrastructure in the region. This statistic highlights the importance of North America in the global apheresis market and underscores its prominent position in driving advancements and innovation within the industry.
The industry faces a possible challenge owing to the high cost of apheresis machines and procedures.
This statistic suggests that the industry is confronted with a potential difficulty due to the significant expense associated with apheresis machines and procedures. Apheresis is a medical procedure that involves separating specific components from a patient’s blood, such as plasma or platelets, and returning the remaining blood components to the patient. The high cost related to apheresis machines, which are sophisticated medical devices used to perform these procedures, as well as the expenses involved in conducting apheresis procedures, pose a challenge for the industry. This financial burden may impact access to apheresis treatments for patients in need and may require industry stakeholders to explore cost-effective solutions or alternative funding strategies to ensure continued access to this vital medical intervention.
Hemodialysis sector is projected to hold a significant industry share accounting for USD 2.2 billion by 2026.
This statistic indicates that the hemodialysis sector is expected to have a notable presence within the industry, with a projected estimated market value of USD 2.2 billion by the year 2026. This suggests that the hemodialysis sector is anticipated to contribute significantly to the overall market size and growth in the healthcare industry. The projected industry share highlights the importance and prominence of hemodialysis services and equipment in addressing the needs of patients with kidney-related conditions. This forecasted value also serves as an indicator of the potential market opportunities and demand for hemodialysis products and services in the near future.
The therapeutic apheresis sector held a substantial share of around 65.3% in the global market in 2019.
The given statistic indicates that the therapeutic apheresis sector, which involves the removal of specific components from a patient’s blood, maintained a significant portion of approximately 65.3% in the worldwide market in the year 2019. This suggests that therapeutic apheresis procedures were in high demand and widely utilized within the healthcare industry during that period. The substantial market share implies that therapeutic apheresis was a prominent and preferred treatment option for various medical conditions, underscoring its importance and impact within the global healthcare landscape.
Disposable apheresis kits are expected to reach USD 3.5 billion by 2030.
This statistic indicates the projected monetary value of disposable apheresis kits by the year 2030, estimated to be USD 3.5 billion. Apheresis is a medical procedure involving the separation of specific components from a patient’s blood. Disposable apheresis kits are essential for performing this procedure as they provide the necessary equipment and materials that can be used only once for one patient to ensure safety and sterility. The expected growth in the market value of disposable apheresis kits suggests a rising demand for apheresis procedures in various healthcare settings, potentially driven by advancements in medical technology, increasing prevalence of diseases requiring apheresis treatment, and a growing focus on personalized medicine.
Europe’s apheresis market accounted for USD 597.5 million in 2019.
The statistic ‘Europe’s apheresis market accounted for USD 597.5 million in 2019’ represents the total monetary value of apheresis procedures and equipment within the European market during the specified year. Apheresis is a medical procedure that involves separating blood components and removing specific substances before returning the blood to the donor or patient. The USD 597.5 million figure indicates the financial scale of apheresis services and products in Europe, highlighting the significant economic activity and investment in this field within the region. This statistic is crucial for stakeholders in the healthcare industry, including healthcare providers, manufacturers, and policymakers, for assessing market trends, making business decisions, and planning future strategies related to apheresis technologies and services in Europe.
By 2030, the apheresis market in the Asia-Pacific region will reach approximately USD 1.58 billion.
The statistic suggests that by the year 2030, the apheresis market within the Asia-Pacific region is projected to expand significantly, with an estimated value of approximately USD 1.58 billion. This indicates substantial growth potential in the sector, likely driven by factors such as increasing awareness and adoption of apheresis procedures, advancements in healthcare technology, rising incidences of chronic diseases, and evolving regulatory frameworks. The substantial market value highlights the growing importance of apheresis therapies in the region, pointing towards a promising future for the industry with significant opportunities for healthcare providers, manufacturers, and investors to capitalize on the expanding market demand for apheresis products and services in the Asia-Pacific region.
The Asian apheresis equipment industry is estimated to grow by 12.45% CAGR between 2018-2026.
The statistic “The Asian apheresis equipment industry is estimated to grow by 12.45% CAGR between 2018-2026” indicates the expected Compound Annual Growth Rate (CAGR) for this specific industry in the Asian region over the period from 2018 to 2026. A CAGR of 12.45% suggests a steady and relatively rapid pace of growth for the apheresis equipment sector in Asia, with the industry’s overall value projected to increase substantially over the specified timeframe. This statistic reflects a positive trend in demand and market expansion for apheresis equipment in Asia, potentially driven by factors such as technological advancements, increasing healthcare infrastructure, and rising awareness and adoption of apheresis procedures in the region.
Photopheresis Market accounted for USD 238.3 million in 2019.
The statistic “Photopheresis Market accounted for USD 238.3 million in 2019” indicates the total value of the market for photopheresis procedures and related products for the year 2019. This figure represents the amount of money generated from the sales of photopheresis equipment, consumables, and services within a specific time frame. The market size of USD 238.3 million suggests a significant demand for photopheresis treatments, which is a specialized therapy used in the treatment of conditions such as graft-versus-host disease, organ transplant rejection, and autoimmune disorders. This statistic provides insights into the economic value and scale of the photopheresis market in 2019, reflecting the industry’s size and potential growth opportunities.
The collected platelets via apheresis method account for nearly 85% of the total platelets collected in the US.
The statistic implies that the apheresis method is a predominant technique for collecting platelets in the United States, representing a significant majority of the total platelets collected. Apheresis is a specialized blood donation process where only specific components such as platelets are extracted, while the remaining blood components are returned to the donor. The high percentage of platelets collected via apheresis suggests its importance in meeting the demand for platelet transfusions in various medical procedures, particularly for patients with clotting disorders, cancer, or undergoing surgeries. These findings highlight the efficiency and effectiveness of the apheresis method in contributing a substantial portion of the nation’s platelet supply.
By 2024, the leukapheresis market is anticipated to reach USD 35 million.
The statistic ‘By 2024, the leukapheresis market is anticipated to reach USD 35 million’ indicates a projection for the total market value attributable to leukapheresis by the year 2024. Leukapheresis is a medical procedure used to separate white blood cells from the blood, often performed for therapeutic purposes such as in patients undergoing cancer treatment or organ transplantation. The projected value of USD 35 million suggests an expected increase in demand for leukapheresis services and products by 2024, potentially driven by advancements in medical technology, an aging population, and an increasing prevalence of conditions that require leukapheresis. This statistic can inform stakeholders in the healthcare industry about the potential growth opportunities in the leukapheresis market in the near future.
Plasmapheresis is in major demand due to the increase in demand for plasma derived medicines which demonstrates an estimated annual growth of 6.2%.
The statistic indicates that there is a significant demand for plasmapheresis, a process used to collect plasma from donors, driven by the growing need for plasma-derived medications. The estimated annual growth rate of 6.2% suggests a notably increasing trend in the demand for plasmapheresis services. This growth is likely attributed to the rising awareness and utilization of plasma-derived medicines in the healthcare industry. The statistic highlights the importance of plasmapheresis as a vital component in meeting the demand for these medications and underscores the potential for continued growth and significance of this process in the healthcare sector.
Hospitals are the largest end-user of apheresis equipment, held over 50% market share in 2019.
The statistic suggests that hospitals are the primary consumers of apheresis equipment and accounted for more than half of the market share in 2019. This indicates that hospitals play a significant role in the utilization of apheresis technology for various medical procedures, such as blood component separation and therapeutic treatments. The high market share held by hospitals highlights their reliance on apheresis equipment to facilitate critical healthcare services and treatments, underscoring the importance of these devices in the healthcare industry. The dominance of hospitals as end-users of apheresis equipment implies a strong demand for these tools within the healthcare sector, reflecting their integral role in delivering quality patient care and medical treatments.
Increase in blood donations is projected to drive demand for apheresis devices, as around 117.4 million blood donations were gathered globally in 2017.
This statistic suggests that the expected rise in blood donation rates is likely to lead to an increased demand for apheresis devices. Apheresis devices are used in the process of collecting specific blood components from donors, allowing for a more targeted approach to blood transfusions and therapies. The sizable number of global blood donations in 2017, totaling 117.4 million units, indicates a substantial supply of blood that can be used for medical purposes. As the number of blood donations continues to increase, particularly with the ongoing push for donations worldwide, there will be a corresponding need for more apheresis devices to effectively and efficiently extract specific blood components for various medical treatments.
The number of apheresis procedures is escalating at a rapid rate of 10%-15% per annum due to the rising prevalence of blood disorders.
The statistic indicates that the number of apheresis procedures, a medical process involving the separation and extraction of specific components from a patient’s blood, is increasing significantly each year by 10% to 15%. This escalation is primarily attributed to the growing prevalence of blood disorders within the population. As blood disorders become more common, the demand for apheresis procedures, which are often utilized in the treatment of these conditions, is also rising. This trend underscores the importance of advancements in medical technologies and procedures to meet the healthcare needs of individuals affected by blood disorders, highlighting the need for improved access to apheresis services and resources to address this increasing demand.
References
0. – https://www.www.transparencymarketresearch.com
1. – https://www.www.grandviewresearch.com
2. – https://www.www.gminsights.com
3. – https://www.www.inkwoodresearch.com
4. – https://www.www.marketsandmarkets.com
5. – https://www.www.psmarketresearch.com
6. – https://www.www.globenewswire.com
7. – https://www.www.marketdataforecast.com
